Cargando…
A Monomeric Variant of Insulin Degrading Enzyme (IDE) Loses Its Regulatory Properties
BACKGROUND: Insulin degrading enzyme (IDE) is a key enzyme in the metabolism of both insulin and amyloid beta peptides. IDE is unique in that it is subject to allosteric activation which is hypothesized to occur through an oligomeric structuture. METHODOLOGY/PRINCIPAL FINDINGS: IDE is known to exist...
Autores principales: | Song, Eun Suk, Rodgers, David W., Hersh, Louis B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838795/ https://www.ncbi.nlm.nih.gov/pubmed/20300529 http://dx.doi.org/10.1371/journal.pone.0009719 |
Ejemplares similares
-
Insulin-degrading enzyme is not secreted from cultured cells
por: Song, Eun Suk, et al.
Publicado: (2018) -
Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's Disease
por: Carrasquillo, Minerva M., et al.
Publicado: (2010) -
An Extended Polyanion Activation Surface in Insulin Degrading Enzyme
por: Song, Eun Suk, et al.
Publicado: (2015) -
Cysteine 904 Is Required for Maximal Insulin Degrading Enzyme Activity and Polyanion Activation
por: Song, Eun Suk, et al.
Publicado: (2012) -
Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging
por: Corraliza-Gomez, Miriam, et al.
Publicado: (2023)